Literature DB >> 32056910

Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome.

Carra A Simpson1, Andre Mu2, Nick Haslam3, Orli S Schwartz4, Julian G Simmons5.   

Abstract

Background Anxiety/depression and irritable bowel syndrome (IBS) are highly prevalent and burdensome conditions, whose co-occurrence is estimated between 44 and 84%. Shared gut microbiota alterations have been identified in these separate disorders relative to controls; however, studies have not adequately considered their comorbidity. This review set out to identify case-control studies comparing the gut microbiota in anxiety/depression, IBS, and both conditions comorbidly relative to each other and to controls, as well as gut microbiota investigations including measures of both IBS and anxiety/depression. Methods Four databases were systematically searched using comprehensive search terms (OVID Medline, Embase, PsycINFO, and PubMed), following PRISMA guidelines. Results Systematic review identified 17 studies (10 human, 7 animal). Most studies investigated the gut microbiota and anxiety/depression symptoms in IBS cohorts. Participants with IBS and high anxiety/depression symptoms had lower alpha diversity compared to controls and IBS-only cohorts. Machine learning and beta diversity distinguished between IBS participants with and without anxiety/depression by their gut microbiota. Comorbid IBS and anxiety/depression also had higher abundance of Proteobacteria, Prevotella/Prevotellaceae, Bacteroides and lower Lachnospiraceae relative to controls. Limitations A large number of gut microbiota estimation methods and statistical techniques were utilized; therefore, meta-analysis was not possible. Conclusions Well-designed case-control and longitudinal studies are required to disentangle whether the gut microbiota is predicted as a continuum of gastrointestinal and anxiety/depression symptom severity, or whether reported dysbiosis is unique to IBS and anxiety/depression comorbidity. These findings may inform the development of targeted treatment through the gut microbiota for individuals with both anxiety/depression and IBS.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Anxiety; Depression; Gut microbiota; Irritable bowel syndrome; Microbiome; Systematic review

Mesh:

Year:  2020        PMID: 32056910     DOI: 10.1016/j.jad.2020.01.124

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  31 in total

1.  Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.

Authors:  Chengjiao Yao; Yilin Li; Lihong Luo; Fengjiao Xie; Qin Xiong; Tinglin Li; Chunrong Yang; Pei-Min Feng
Journal:  Dig Dis Sci       Date:  2022-05-03       Impact factor: 3.199

2.  Exploring the association between microbiota and behaviour in suckling piglets.

Authors:  R Choudhury; A Middelkoop; J E Bolhuis; M Kleerebezem
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

3.  An Open-Label Trial Study of Quality-of-Life Assessment in Irritable Bowel Syndrome and Their Treatment.

Authors:  Bogdana Ariana Alexandru; Lavinia Alina Rat; Andrada Florina Moldovan; Petru Mihancea; Lavinia Mariș
Journal:  Medicina (Kaunas)       Date:  2022-06-05       Impact factor: 2.948

Review 4.  Fecal Microbiota Transplantation and Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.

Authors:  Yapeng Li; Tingting Zhang; Jiahui Sun; Nanyang Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-27       Impact factor: 6.073

5.  Toward a better understanding of intermittent fasting effects: Ramadan fasting as a model.

Authors:  Suhaib K Abdeen; Eran Elinav
Journal:  Am J Clin Nutr       Date:  2021-05-08       Impact factor: 7.045

6.  Transcriptional markers of excitation-inhibition balance in germ-free mice show region-specific dysregulation and rescue after bacterial colonization.

Authors:  Vivek Philip; Dwight F Newton; Hyunjung Oh; Stephen M Collins; Premysl Bercik; Etienne Sibille
Journal:  J Psychiatr Res       Date:  2021-01-19       Impact factor: 4.791

7.  A Comprehensive Self-Management Program With Diet Education Does Not Alter Microbiome Characteristics in Women With Irritable Bowel Syndrome.

Authors:  Kendra J Kamp; Anna M Plantinga; Kevin C Cain; Robert L Burr; Pamela Barney; Monica Jarrett; Ruth Ann Luna; Tor Savidge; Robert Shulman; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2021-01-08       Impact factor: 2.318

8.  Ingestion of probiotic (Lactobacillus helveticus and Bifidobacterium longum) alters intestinal microbial structure and behavioral expression following social defeat stress.

Authors:  Katherine A Partrick; Anna M Rosenhauer; Jérémie Auger; Amanda R Arnold; Nicole M Ronczkowski; Lanaya M Jackson; Magen N Lord; Sara M Abdulla; Benoit Chassaing; Kim L Huhman
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

Review 9.  Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.

Authors:  Yoshiyuki Mishima; Shunji Ishihara
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

Review 10.  Autism Spectrum Disorder Associated With Gut Microbiota at Immune, Metabolomic, and Neuroactive Level.

Authors:  Enriqueta Garcia-Gutierrez; Arjan Narbad; Juan Miguel Rodríguez
Journal:  Front Neurosci       Date:  2020-10-08       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.